Laboratory-treated autologous lymphocytes
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Laboratory-treated autologous lymphocytes, covering 2014-12-17 to 2015-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung Cancer [Phase 1]